Biotech

All Articles

A nearer check out Tough Biotech's Intense 15

.In this particular week's incident of "The Top Pipe," our experts're diving in to Ferocious Biotech...

Lilly experiences stage 2 breakdown of tau-targeting med

.The confetti is still soaring from Eli Lilly's celebration celebrating the commendation of Alzheime...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of significant leadership hirings, shootings...

Lykos are going to ask FDA to reexamine its decision observing being rejected of MDMA treatment for trauma

.Adhering to an inadequate presenting for Lykos Therapies' MDMA prospect for post-traumatic stress d...

AN 2 halves roll call, stops period 3 test after data dissatisfy

.AN2 Therapeutics is actually reviewing its organization in reaction to poor midphase data, swearing...

Merck pays out $700M for bispecific, snooping autoimmune position and also opportunity to test Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 million in advance to challenge Amgen in a blood cancer ...

Gilead spends J&ampJ $320M to exit licensing offer for seladelpar

.Along With Gilead Sciences about to an FDA selection for its liver illness medicine seladelpar, the...

' All hands on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can see the providers putting together outdoors tents at baseca...

Entero laying off workers, moving out of workplace and also stopping R&ampD

.Bed mattress Liquidators has turned Entero Rehabs white as a sheet. The creditor bought Entero to r...

Exelixis loses ADC after determining it's no suit for Tivdak

.Exelixis is actually surrendering on its tissue element (TF)- targeting antibody-drug conjugate aft...